Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

United States Cardiac Assist Devices Market Outlook to 2021

Be the first to review this product

United States Cardiac Assist Devices Market Outlook to 2021

Summary

GlobalData's new report, 'United States Cardiac Assist Devices Market Outlook to 2021', provides key market data on the United...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,995.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

United States Cardiac Assist Devices Market Outlook to 2021

Summary

GlobalData's new report, 'United States Cardiac Assist Devices Market Outlook to 2021', provides key market data on the United States Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiac Assist Devices market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Assist Devices market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Assist Devices market.
- Key players covered include Thoratec Corporation, Maquet Holding B.V. & Co. KG., HeartWare International, Inc., Teleflex Incorporatedand Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 88
Publication date 18 Jan 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Cardiac Assist Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Cardiac Assist Devices Market, United States 10
3.1 Cardiac Assist Devices Market, United States, Revenue ($m), 2007-2014 10
3.2 Cardiac Assist Devices Market, United States, Revenue ($m), 2014-2021 12
3.2.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2007-2014 14
3.2.2 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2007-2014 16
3.2.3 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2014-2021 18
3.2.4 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2014-2021 20
3.3 Cardiac Assist Devices Market, United States, Volume (Units), 2007-2014 22
3.4 Cardiac Assist Devices Market, United States, Volume (Units), 2014-2021 24
3.4.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2007-2014 26
3.4.2 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2007-2014 28
3.4.3 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2014-2021 30
3.4.4 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2014-2021 32
3.5 Cardiac Assist Devices Market, United States, Average Price ($), 2007-2021 34
3.6 Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014 36
3.7 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2014 37
4 Overview of Key Companies in United States, Cardiac Assist Devices Market 39
4.1 Thoratec Corporation 39
4.1.1 Company Overview 39
4.2 HeartWare International, Inc. 39
4.2.1 Company Overview 39
4.3 Maquet Holding B.V. & Co. KG. 39
4.3.1 Company Overview 39
4.4 Teleflex Incorporated 40
4.4.1 Company Overview 40
4.5 SynCardia Systems, Inc. 40
4.5.1 Company Overview 40
5 Cardiac Assist Devices Market Pipeline Products 41
6 Financial Deals Landscape 42
6.1 Acquisition 42
6.1.1 Abbott Labs Denies Talks to Acquire St. Jude Medical for USD25 Billion 42
6.1.2 Medtronic Acquires Aptus Endosystems for USD110 Million 43
6.2 Equity Offerings 45
6.2.1 Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units 45
6.2.2 Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 47
6.3 Venture Financing 49
6.3.1 Procyrion Raises USD10 Million in Series B Financing Round 49
6.3.2 Ariste Medical Raises USD4.6 Million in Venture Financing 50
6.3.3 Contego Medical Raises USD5.6 Million in Series B Financing 51
6.3.4 Sunshine Heart Secures USD6 Million from Silicon Valley Bank 52
7 Recent Developments 54
7.1 Corporate Communications 54
7.1.1 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 54
7.1.2 Nov 04, 2015: Ventripoint Announces New Director and Provides Corporate Update 54
7.1.3 Oct 27, 2015: Micron Products Expands Sales Organization to Meet Growing Demand for Highly-Engineered Contract Manufacturing Services 55
7.1.4 Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team 56
7.1.5 Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan 56
7.1.6 Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors 58
7.1.7 Apr 28, 2015: Arrhythmia Research Technology Appoints Robert A. Mello to Board of Directors 58
7.1.8 Mar 25, 2015: Ventripoint Announces Resignation of Director 59
7.1.9 Mar 18, 2015: Spectranetics Announces Chief Financial Officer Transition 59
7.2 Financial Announcements 59
7.2.1 Nov 12, 2015: Arrhythmia Research Technology Reports 2015 Third Quarter Results 59
7.2.2 Aug 25, 2015: Clementia Pharmaceuticals Expands Ongoing Phase 2 Study to Include Children with Fibrodysplasia Ossificans Progressiva 61
7.2.3 Aug 13, 2015: Arrhythmia Research Technology Reports 2015 Second Quarter Results 63
7.2.4 Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results 66
7.2.5 May 13, 2015: Arrhythmia Research Technology Reports First Quarter 2015 Results 67
7.2.6 Apr 22, 2015: St. Jude Medical Reports First Quarter 2015 Results 69
7.2.7 Apr 20, 2015: Positive Clinical Results of OncoCyte's PanC-Dx Diagnostic Test Demonstrate High Level of Sensitivity and Specificity in Non-Invasive Detection of Bladder Cancer 70
7.2.8 Feb 20, 2015: St. Jude Medical Announces Increase in Quarterly Dividend 71
7.2.9 Jan 28, 2015: St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results 71
7.2.10 Jan 14, 2015: St. Jude Medical Announces Preliminary Fourth Quarter Financial Results 73
7.3 Government and Public Interest 74
7.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 74
7.4 Legal And Regulatory 75
7.4.1 Jan 13, 2015: Ventripoint Announces Completion of Initial Establishment Inspection by FDA 75
7.5 Other Significant Developments 76
7.5.1 Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results 76
7.5.2 Mar 30, 2015: Ventripoint Announces Distribution Partner for Military and VA Medical Centers 78
7.6 Product News 78
7.6.1 Mar 25, 2015: New stent devices can limit stroke damage, says Loyola neurosurgeon 78
8 Appendix 80
8.1 Research Methodology 81
8.1.1 Coverage 81
8.1.2 Secondary Research 81
8.1.3 Primary Research 82
8.1.4 Market Modeling and Forecasting 83
8.1.5 Company Share Analysis 86
8.1.6 Distribution Share Analysis 87
8.2 Expert Panel 88
8.3 GlobalData Consulting 88
8.4 Contact Us 88
8.5 Disclaimer 88

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.